Literature DB >> 8169429

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases.

D L Thomas1, R O Cannon, C N Shapiro, E W Hook, M J Alter, T C Quinn.   

Abstract

The seroprevalences of and risk factors for hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), and syphilis were determined among 1257 consecutive non-intravenous drug-using patients attending Baltimore sexually transmitted diseases clinics: 122 (9.7%) had antibodies to HCV (anti-HCV), 192 (15.3%) had antibodies to HBV (anti-HBc), 44 (3.5%) had antibodies to HIV (anti-HIV), and 60 (4.8%) were seropositive for syphilis. For males, independent predictors of anti-HCV were age > 29 years and lack of condom use in the month before their visit. Males with any one serologic marker (anti-HCV, anti-HBc, anti-HIV, or syphilis) were more likely to have each of the other markers. For females, anti-HCV was independently associated with age > 29 years and > 1 male sex partner in the prior month. Females with anti-HIV or anti-HBc were more likely to have anti-HCV. These observations among non-intravenous drug-using patients suggest that sexual transmission of HCV may occur.

Entities:  

Mesh:

Year:  1994        PMID: 8169429     DOI: 10.1093/infdis/169.5.990

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

Review 1.  Hepatitis C: medical information update. Canadian Liver Foundation. National Hepatitis C Education Program.

Authors: 
Journal:  Can J Public Health       Date:  2000 Jul-Aug

2.  Sexual co-transmission of HIV, hepatitis B, and hepatitis C viruses.

Authors:  S Singh; D M Thappa; T J Jaisankar; S Sujatha
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

3.  Hepatitis C virus infection in cocaine users--a silent epidemic.

Authors:  H H Harsch; J Pankiewicz; A S Bloom; C Rainey; J K Cho; L Sperry; E A Stein
Journal:  Community Ment Health J       Date:  2000-06

4.  Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group.

Authors:  R S Remis; A Dufour; M Alary; J Vincelette; J Otis; B Mâsse; B Turmel; R LeClerc; R Parent; R Lavoie
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

5.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

6.  Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Authors:  C Matheï; E Wollants; J Verbeeck; M Van Ranst; G Robaeys; P Van Damme; F Buntinx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

Review 7.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

8.  Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening.

Authors:  R Irvin; A McAdams-Mahmoud; D Hickman; J Wilson; W Fenwick; I Chen; N Irvin; O Falade-Nwulia; M Sulkowski; R Chaisson; D L Thomas; S H Mehta
Journal:  J Community Med Health Educ       Date:  2016-05-30

9.  The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.

Authors:  Joe Sasadeusz; Jennifer Audsley; Anne Mijch; Rachel Baden; Jose Caro; Hermeyone Hunter; Gail Matthews; Moira A McMahon; Susan A Olender; Robert F Siliciano; Sharon R Lewin; Chloe L Thio
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

10.  Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida.

Authors:  J S Weisbord; M J Trepka; G Zhang; I P Smith; T Brewer
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.